Analyst Ranking
Top 35%
#1842 out of 5279 analysts
Average Return
+2.07%
Win Rate
56%14 out of 25
Risk vs Reward
Poor
Good

Jason N. Butler's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cytokinetics IncCYTK
+54.07%$49.62$76.45
2025-09-01 -
2026-05-19
Buy
Terawulf IncWULF
+47.17%$14.50$21.34
2025-10-28 -
2026-05-19
Buy
Abivax SaABVX
+38.70%$82.00$113.73
2025-09-24 -
2026-05-19
Buy
Gh Research PLCGHRS
+37.73%$15.93$21.94
2026-03-05 -
2026-05-19
Buy
Rapport Therapeutics IncRAPP
+33.94%$25.66$34.37
2025-11-06 -
2026-05-19
Buy

Jason N. Butler Analyst Color

Get additional color on Jason N. Butler's coverage of popular stocks

Jason N. Butler's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Gh Research PLCGHRS
2Buy$39.00+77.76%Maintains
5 days ago
Precigen IncPGEN
3Buy$11.00+164.42%Maintains
6 days ago
Avalo Therapeutics IncAVTX
2Buy$55.00+238.05%Maintains
6 days ago
Prothena Corp Public Ltd CoPRTA
1Buy$20.00+120.51%Maintains
12 days ago
Cormedix IncCRMD
2Buy$19.00+142.97%Reiterates
22 days ago
Minerva Neurosciences IncNERV
1Buy$14.00+221.10%Initiates Coverage On
a month ago
Nasus Pharma LtdNSRX
1Buy$18.00+566.67%Maintains
2 months ago
Esperion Therapeutics IncESPR
1Buy$5.00+59.74%Maintains
2 months ago
Argenx SeARGX
1Buy$944.00+18.33%Maintains
3 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$10.00+172.48%Maintains
3 months ago
Acadia Pharmaceuticals IncACAD
3Buy$35.00+70.90%Maintains
3 months ago
Achieve Life Sciences IncACHV
1Buy$19.00+326.97%Initiates Coverage On
6 months ago
Rapport Therapeutics IncRAPP
1Buy$80.00+132.76%Maintains
6 months ago
Terawulf IncWULF
1Buy$22.00+3.09%Maintains
7 months ago
Rezolute IncRZLT
1Buy$17.00+448.39%Maintains
7 months ago
Abivax SaABVX
1Buy$114.00+0.24%Maintains
8 months ago
Cytokinetics IncCYTK
1Buy$78.00+2.03%Reiterates
9 months ago
Zevra Therapeutics IncZVRA
1Buy$18.00+76.47%Maintains
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.